GUMM - Eliminate the Common Cold Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: DanZ who wrote (4137)	6/12/2002 11:27:57 PM
From: Mad2	of 5582

From Gumtech pertaining to Scio Nobels "study" on Zicam allergy relief Disclosure Statement The author Dr. Sion Nobel was employed by Barron Biotechnologies to conduct this study and serve as independent principal investigator. Barron Biotechnologies was contracted by Gumtech International, the manufacturer of Zicam Allergy Relief to organize a clinical allergy study with the drug. The author was paid a nominal fee based on patient enrollment in the study. Barron Biotechnologies is an independent company which has no vested interest in Gumtech. Barron Biotechnologies received some money but no stock or stock options from Gumtech as payment for the contract. No payments of any kind from Gumtech to Barron Biotechnologies or from Barron Biotechnologies to the author were ever dependent upon any outcomes. Don't quite know who Barron Biotechnologies is, assume its a business of Ernesto Barron. Anyway its not a registered US business mad2

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next